Skip to content
10-Q

Quarterly Report

ENTEROLOGICS, INC.

0001477932-12-001596

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 14, 2012 35.91M sh
Capex Q1 2012 · Mar 31, 2012 $300K
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$306.26K
Operating Cash Flow restated Q1 2012 · Mar 31, 2011 −$20.45K
Stockholders Equity Q1 2012 · Mar 31, 2012 $304.08K
Stockholders Equity Q1 2012 · Dec 31, 2011 $362.47K
Stockholders Equity Q1 2012 · Dec 31, 2010 −$20.52K
Stockholders Equity Q1 2012 · Dec 31, 2009 $40.01K
Current Liabilities Q1 2012 · Mar 31, 2012 $218.85K
Current Liabilities Q1 2012 · Dec 31, 2011 $166.2K
Total Liabilities Q1 2012 · Mar 31, 2012 $285.51K
Total Liabilities Q1 2012 · Dec 31, 2011 $232.86K
Current Assets Q1 2012 · Mar 31, 2012 $13.73K
Current Assets Q1 2012 · Dec 31, 2011 $17.98K
Total Assets Q1 2012 · Mar 31, 2012 $589.59K
Total Assets Q1 2012 · Dec 31, 2011 $595.33K
Sga Expense Q1 2012 · Mar 31, 2012 $69.25K
Sga Expense restated Q1 2012 · Mar 31, 2011 $1.75K
Rd Expense Q1 2012 · Mar 31, 2012 $120.34K
Net Income Q1 2012 · Mar 31, 2012 −$362.11K
Net Income Q1 2012 · Dec 31, 2011 −$223.01K
Net Income restated Q1 2012 · Mar 31, 2011 −$19.3K
Net Income Q1 2012 · Dec 31, 2010 −$72.61K